High Concentration of Medium-Sized HDL Particles and Enrichment in HDL Paraoxonase 1 Associate With Protection From Vascular Complications in People With Long-standing Type 1 Diabetes
Tomáš Vaisar, Karin Bornfeldt(University of Washington), Carla J. Greenbaum(Society of Interventional Radiology), Hillary A. Keenan(Joslin Diabetes Center), Emily A Wolfson(Joslin Diabetes Center), Angela D. Irwin(University of Washington), Hetal Shah(Joslin Diabetes Center), Jay W. Heinecke(University of Washington), Jake Wimberger(University of Washington), I‐Hsien Wu(Joslin Diabetes Center), Vanessa Bahnam(Joslin Diabetes Center), Jenny E. Kanter(University of Washington), J Gauthier(Joslin Diabetes Center), George L. King(Joslin Diabetes Center)
Cited by 71
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.
|Journal of Clinical Investigation|1994|1.3k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k